Q1FY27 results: PAT rises 28% YoY standalone; IPO funds fully utilised
GSPCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.9 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
GSP Crop Science reported Q1FY27 standalone revenue of Rs 4,242.05 mn versus Rs 4,002.42 mn YoY and PAT of Rs 312.82 mn, up 28% YoY. Consolidated revenue stood at Rs 3,859.95 mn and PAT at Rs 263.94 mn. Standalone EPS was Rs 6.72. Net IPO proceeds of Rs 1,130.53 mn are now fully utilised with no deviation reported by CRISIL. Board set 41st AGM for Sept 18, 2026 and appointed a new Independent Director.
Strong profit growth and clean IPO fund use signal healthy fundamentals; director and auditor changes are routine governance updates.